43 Childrens Medications Recalled by Johnson and Johnson

Late Friday, April 30, Johnson and Johnson, in a join statement with the U.S. Food and Drug Administration (FDA), announced the recall of 43 different children’s, over the counter, pain and allergy medications. The recall involves over 1000 Johnson and Johnson production lot numbers.

Initiated by Johnson and Johnson’s internal product monitoring division, the McNeil Consumer Health Care Unit, the recall lists 24 Children’s Tylenol items, 14 Children’s Motrin items, 5 Children’s Zyrtec items and 1 Children’s Benadryl product.

A complete list of the items and the lot numbers involved is available at the FDA’s website.
Johnson and Johnson states that the products contain abnormally high levels of active and inactive ingredients or small metallic particles. Only a remote chance of health related consequences is possible according to the FDA.

According to Johnson and Johnson, and the FDA, no person has reported illness or side effects from the products but consumer complaints that they would not elaborate on sparked the investigation.

A spokesperson for McNeil Consumer Healthcare, Bonnie Jacobs, said that the company had discovered the problem and launched an internal inquiry that resulted in a notification to the FDA that they, Johnson and Johnson, were issuing a recall.

The FDA, on the other hand, says that they uncovered the problems during a normal inspection of the factory and detailed the issues in a letter to the company on Friday morning that initiated the recall.
Johnson and Johnson have issued multiple recalls since 2009 involving production problems with its medications.